pis...(put something here)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Right, good memory - could't think of it - if I'm not mistatken there was another name before that one too!
MODG - news just out - I'm in this at .02
Immediatek and LCD Interactive Form Exclusive Partnership on Breakthrough
Technology to Enable Music
Downloads While Protecting Copyrights
Business, Entertainment Editors & High Tech Writers
RICHARDSON, Texas--(BUSINESS WIRE)--Dec. 11, 2002--Immediatek,
Inc. (OTCBB:MODG) today announced that it has formed a strategic
alliance with LCD Interactive, Inc., a privately held company that has
developed breakthrough technology enabling Internet music fans to
download standard MP3 files directly to their CD burners, while
protecting the artists' copyrights.
Immediatek says the alliance with LCD, headquartered in Frisco,
Texas, provides the company with an exclusive agreement to further
develop and co-market the technology. Immediatek's CEO Zach Bair
comments that the technology could provide a standards-based solution
for the music industry's burgeoning problems with downloadable music.
Immediatek has also entered early discussions concerning the possible
acquisition of LCD Interactive.
According to Bair and Paul Marin, CEO of LCD, the technology is in
use on LCD's Web site TwoBigToes.com, which has a library of more than
30,000 MP3 files from independent artists and even some well-known
artists such as multi-platinum artist Shania Twain. Users are able to
download and burn MP3 music files directly to a CD-R, completely
bypassing the user's hard disk, thereby offering a secure way of
legally delivering music to fans onto CD-Rs.
Artist's royalties are guaranteed and are tracked and paid through
TwoBigToes' unique "STAMPS" program, which stands for "Sales Trends
And Music Payment Status."
"The problem with software such as Napster and Gnutella is that
files are freely traded among users," says Bair. "With this
technology, artists, labels, and music distributors have a method to
control copyrights utilizing standard MP3 files. No additional
encryption is necessary."
Marin adds the technology is transportable and is being readied
for other formats such as DVD.
Immediatek expects to start discussions with major labels, artists
and distributors almost immediately, and two pending music-related
agreements are expected to be announced in the next several days.
ABOUT IMMEDIATEK:
Immediatek, Inc. (www.immediatek.com) (OTCBB:MODG) is an Efficient
Solutions Provider (ESP) specializing in Fortune 500-quality computing
and infrastructure support and software solutions, utilizing
innovative methods and processes coupled with outstanding customer
service to effectively reinvent and change the way people think about
information technology. In addition to it's innovative TekNet
OnCall(TM) support product line, Immediatek also offers such
professional solutions as business process re-engineering through the
use of technology, as well as a wide array of web and internet
services. The company is based in Richardson, Texas, and was founded
in 2001 by Zach Bair, who is also the founder of venture-backed
PowerUp Networks. PowerUp has so far received over $29 million in
funding based on automation software of Bair's design that was
initially implemented at Sabre, Inc.
ABOUT LCD INTERACTIVE:
LCD Interactive, Inc. offers a proprietary "one-click" CD burning
software that protects copyright owners and musicians. Unlike Roxio,
LCD's software allows music to download from the Internet and
instantly and automatically burn to a compact disc recordable (CD-R)
in "one click". LCD is the only software capable of downloading an
entire music CD from the Internet surpassing the computer's hard drive
and burning music directly to a compact disc recordable. In addition
to the music, LCD's software downloads CD cover art, liner notes and
song tracks for printing. LCD's "one-click" burning software is
compatible with all CD burners in the marketplace and is the only
company to offer digital music that downloads and burns directly from
the Internet to a CD-R in one simple click
For more information on Immediatek please contact:
--30--mjr/da*
CONTACT: Immediatek, Inc.
Zach Bair, 214/712-7336
or
Michael A. Burns & Assoc, PR
Jennifer Green, 214/521-8596
jgreen@mbapr.com
KEYWORD: TEXAS
INDUSTRY KEYWORD: COMPUTERS/ELECTRONICS ENTERTAINMENT INTERNET
MUSIC SOFTWARE MARKETING AGREEMENTS PRODUCT
SOURCE: Immediatek, Inc.
Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
URL: http://www.businesswire.com
Dec-11-2002 14:45 GMT
Symbols:
US;MODG
Source BW Business Wire
Categories:
MST/R/US/TX MST/I/ENT MST/I/NET MST/I/MOV MST/I/SOF MST/S/PDT
MST/S/PDT
Jane,
Do you remember the name of his thread before he renamed it The Good-The Bad and The Ugly?
Here is his thread on SI:
http://www.siliconinvestor.com/stocktalk/subject.gsp?subjectid=36574
He was a cantankerous type without a doubt. Outspoken and getting into many confrontations with others. I use to be a part of his thread years ago, but got annoyed at the bickering and complaining and haven't ventured there in a long time - didn't even know he was still around posting at SI (he was suspended many times).
He was one of SI's biggest stock guru's during the stock market heyday! He ran a thread there that was probably one of the most-read one's at the time.
Anyone know if this post is true:
http://www.siliconinvestor.com/stocktalk/subject.gsp?subjectid=53511
OZLU - .11 X .115
OZLU news:
OZLU's ELCE Water Activator Test Boosts Shrimp Larvae Development Dramatically,
Increases Size by Up to 20% At
Panama Cultivation Farm
Business Editors
TORONTO--(BUSINESS WIRE)--Dec. 10, 2002--
Survival Rate Jumps from 70% to 92%; CEO Sees "Significant Potential"
Ozolutions. Inc. (OTCBB:OZLU) had "extremely positive" news about
the advanced technology ELCE "water activator" it markets.
The product passed a year-long test of its effectiveness at
a Panamanian shrimp nursery, Pacific Larval Centre Inc. The ELCE
activator technology increased larvae size up to 20%, and boosted the
survival rate of the shrimp larvae from 70% to 92%.
Bronchial development, a key indicator of strong, healthy strong
growth, achieved 100% of the anticipated development in only 9 to 10
days, compared with the traditional average of 60% to 80% development
after the full 19-day development cycle.
Pacific Larval produces and cultivates shrimp larvae supplying
them to shrimp farms in Central and South America for further growing
and commercial sale. ELCE activation was also used to treat algae (the
basic food of the larvae) and was found to improve the growth
enhancing characteristics of this food source.
Ozolutions has been testing ELCE water activation on both the
algae and larvae to demonstrate the effectiveness of the process,
which sends water through tumbling ceramic balls, creating electrical
charges and improving the properties of the water.
Ozolutions has been awaiting positive results from this year of
testing, before launching a sales campaign to the shrimp industry of
Central and South America and the Caribbean.
Said Ozolutions President Max Weissengruber: "There are clear
indications that by improving the growth-enhancing characteristics of
algae, the food source for shrimp larvae, and by using ELCE water
activation in the laboratory tanks in which the larvae are grown,
significant larvae growth and development can be achieved while the
average mortality rate is reduced.
"There are significant numbers of shrimp larvae laboratories in
Central and South America," he said, "and Ozolutions intends to
vigorously pursue these opportunities now that there is clear evidence
of the commercial productivity improvements to be gained from ELCE
technology."
Ozolutions is now installing similar ELCE test units at scallop,
salmon and black cod operations in Canada.
"We believe that there is great potential for Ozolutions to
promote the use of ELCE water activation in a wide variety of
aquacultural industries where steady growth, high survival rates and
overall healthy development are key commercial objectives for these
important food industries," said Weissengruber.
Safe Harbour Statement under the Private Securities Act of 1995.
Except for the historical information herein, the matters discussed in
this press release are forward-looking statements that involve risks
and uncertainties, including but not limited to economic, competitive,
governmental and technological factors affecting the Company's
operations, markets, products and prices, and other factors discussed
in the Company's various filings with the Securities and Exchange
Commission.
--30--MJB/ho*
CONTACT: Ozolutions Inc., Toronto
Max Weissengruber, 416/490-0254
Fax: 416/495-8625
www.ozolutions.com
or
ELCE International
Claudio Sgarbi, (41) 91-6469022
Fax: (41) 91-6467760
www.elce.ch
KEYWORD: INTERNATIONAL CANADA LATIN AMERICA
INDUSTRY KEYWORD: FOODS/BEVERAGES
SOURCE: Ozolutions
Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
URL: http://www.businesswire.com
Dec-10-2002 14:06 GMT
Symbols:
US;OZLU
Source BW Business Wire
Categories:
MST/R/CA MST/R/LTM MST/I/FOD
CMGI looking great in PM - good move, bb!
WHIP I hope you punched out the entire "chad" when you cast your vote!LOL
DNAP - Great volume today and nice price increase - will it continue or crash tomorrow? - that is the question!
WHIP:
They've been known to crash on news - hopefully this one will get the word out.
DNAP - news just out:
http://www.investorshub.com/boards/read_msg.asp?message_id=616497
DNAPrint Launches Revolutionary Pan-Genome Screening Platform Based on Ancestral
/FROM PR NEWSWIRE MIAMI 305-461-8666/
TO BUSINESS, MEDICAL AND SCIENCE EDITORS:
DNAPrint Launches Revolutionary Pan-Genome Screening Platform Based on
Ancestral Admixture Mapping
SARASOTA, Fla., Dec. 9 /PRNewswire/ --
DNAPrint genomics, Inc. (OTC Bulletin Board: DNAP) (the "Company"), unveiled a
new whole-genome screening platform (ADMIXMAP) that promises to rapidly change
the landscape of disease and drug response gene hunting. The new platform is
revolutionary because it represents the first yet developed for cost-effective
whole-genome scanning in large, heterogeneous populations. It taps into
sequence differences among the world's various continental population groups
to increase the power and efficiency of pan-genome disease gene screening.
ADMIXMAP will allow DNAPrint to identify new disease and drug response
genes 10 times faster and 1,000-times less expensively than others who use
existing methods. Dr. Tony Frudakis, CEO, informally announced the
introduction of ADMIXMAP to attendees at the invitation-only IBM Life Science
Solution Developer Conference in Boca Raton, FL, and proclaimed the Company's
intent to partner collaborative services based on the platform to pharma,
biotech and academia.
The development of ADMIXMAP was a culmination of years of research into
population genomics structure and human ancestry conducted with Dr. Mark
Shriver of the Pennsylvania State University. The primary focus of the work
was to create an original type of human genome map based on validated and
characterized Ancestry Informative Markers. snAIMs are Single Nucleotide
Polymorphsims (SNPs) of significant allele frequency differences between the
world's various continental population groups; prior to DNAPrint's work, such
a map had not existed. This map is combined with other compositions and new,
highly specialized analytical algorithms to constitute the ADMIXMAP platform.
The platform functions by allowing a fine appreciation of population genomics
structure relevant for solving complex human conditions, and it is based on a
process called Mapping by Admixture Linkage Disequilibrium (MALD) or Admixture
Mapping (AM).
DNA exists in a block like state, and hypothesis-free genome screens aim
to inspect each of several hundred thousand of these blocks for sequence
correlation with disease or drug response. A genome-wide study usually
queries hundreds of genomes. Because each genotype costs about $0.50 and
hundreds of thousands of genotypes need be created per genome, a typical
genome study costs several tens of millions of dollars.
On the other hand, Mapping by Admixture Linkage Disequilibrium (MALD) or
Admixture Mapping (AM) takes advantage of the fact that in recently admixed
populations (i.e. Hispanics or African Americans, among many others), the
block-like structure of DNA extends for MegaBases rather than kilobases
(Chakraborty and Weiss, 1988; Stephens et al., 1994, McKeigue 1998, McKeigue
et al., 2000). Because the DNA is made of a relatively small number of very
large blocks, pan-genome coverage can be obtained with as few as 1,500 markers
at a cost of only $1-2K per sample or a couple hundred thousand dollars per
study.
MALD and AM can only be accomplished using Ancestry Informative Markers
(AIMs) and to its knowledge, the Company is the only to yet mine the human
genome to produce a pan-genome map of validated snAIMs. In addition to a
validated AIM map, the MALD/AM methods also require the determination of
individual ancestry admixture proportions and DNAPrint was the first to reduce
the determination of individual admixture proportions using AIMs to commercial
practice (see www.ancestrybydna.com). As a result, DNAPrint believes it is
the only company in the world capable of practicing the MALD and AM methods.
"The single largest problem drug and diagnostics developers currently face
is the cost associated with genotyping," said Dr. Matt Thomas, DNAPrint's
Chief Molecular Biologist. "Due to this cost, most whole-genome research
today is restricted to isolated, homogeneous populations, which can limit the
general applicability of the results obtained."
"In part, the human genome was sequenced to help us get away from a
restrictive focus on homogeneous, isolated populations for drug and
diagnostics design," said Zack Gaskin, DNAPrint's Chief Technician. "Because
ADMIXMAP is the first platform to enable cost-effective whole genome scans in
heterogeneous populations, we expect it to have a profound impact on genomics-
based drug and diagnostics design and we consider its development to represent
an important milestone in human genome research."
DNAPrint intends to partner this new platform with biotech, pharma and
academia seeking to identify new drug targets and diagnostic tests. Using
this model, partners would fund the work and the Company would retain a share
of the intellectual property produced. DNAPrint hopes to use the method with
partners to discover hundreds or even thousands of disease genes and to
acquire a significant stake in the future of genomics-based medicine. Given
the magnitude of drug and diagnostics royalties, relatively few of the
discovered genes need be developed as drug targets or diagnostic tests to
render the endeavor a success.
About DNAPrint genomics, Inc.
DNAPrint genomics Inc. is a personalized medicine company founded by a
team of scientists with research and commercial experience in high-level
mathematical modeling, programming and molecular genetics. The Company is
traded on the Nasdaq OTC Bulletin Board under the ticker symbol: DNAP. For
more information about the company, please visit www.dnaprint.com.
References contained herein:
1. Chakraborty, R. and K. Weiss. 1988. PNAS 85: 9119-9123.
2. Stephens J.C. Briscoe, D., and O'Brien, S.J. 1994. AJHG 55: 908-924.
3. McKeigue, P.M. 1998. AJHG 63:241-251.
4. McKeigue, P.M., et al., 2000. Ann. Hum. Genet. 64:171-186.
All statements in this press release that are not historical are forward-
looking statements within the meaning of Section 21E of the Securities
Exchange Act as amended. Such statements are subject to risks and
uncertainties that could cause actual results to differ materially from those
projected, including, but not limited to, uncertainties relating to
technologies, product development, manufacturing, market acceptance, cost and
pricing of DNAPrint's products, dependence on collaborations and partners,
regulatory approvals, competition, intellectual property of others, and patent
protection and litigation. DNAPrint genomics, Inc. expressly disclaims any
obligation or undertaking to release publicly any updates or revisions to any
forward-looking statements contained herein to reflect any change in
DNAPrint's expectations with regard thereto or any change in events,
conditions, or circumstances on which any such statements are based.
Media and Press Contacts
Carrie Castillo
DNAPrint genomics, Inc.
Director, Marketing Communications
(941) 366-3400
ccastillo@dnaprint.com
MAKE YOUR OPINION COUNT - Click Here
http://tbutton.prnewswire.com/prn/11690X75671382
SOURCE DNAPrint genomics, Inc.
/CONTACT: Carrie Castillo, Director, Marketing Communications of
DNAPrintgenomics, Inc., +1-941-366-3400, or ccastillo@dnaprint.com/
/Web site: http://www.dnaprint.com /
Dec-09-2002 16:18 GMT
Symbols:
US;DNAP
Source PRN PR Newswire
Categories:
NWR/FL NWI/MTC NWI/OTC NWS/PDT MST/R/US/FL MST/I/DRG MST/I/MKT
MST/S/PDT
CKSWE - now .19 X .20 (I should complain more often - LOL)
Now it's looking a bit better - .18 X .19!
OT - Anyone on this board work or live in Manhattan?
Here's a low volumer that is picking up some speed today with news: OZLU
CKSWE - I got in this one the day it nose dived after the delisting notification - bought more a few days later - this bounce I thought was a no-brainer is taking way longer than I planned.
How sad - I remember him from RB.
LaFem,
Monday and Tuesday were great for me - then the rest of the week has been a real stinker!
FTGX - looks like dog's doo right now - so do a lot of my other holdings! Anyone doing good today - what's trading up?
I did check the AmericanBulls this morning along with a few others:
Chart Indicators
Ind. short Inter Long
EMA VBu VBu Bu
MACD VBu VBu VBu
RSI . Bu .
TDD . Bu .
Fibs Bu N N
Highs N Bu Bu
Lows VBu VBu VBu
Trends N N N
VBu=Very Bullish, Bu=Bullish
N=Neutral
Be=Bearish, VBe=Very Bearish
BREAKOUT WATCH for possible breakout above 0.16, no resistance in area just above.
Type: True breakout from double resistance.
Target: 0.22, +46.7%
and:
http://stockcharts.com/def/servlet/SC.web?c=FTGX&style=BD*******[VB20]
bb or WHIP or any chartist specialist:
What is your opinion on FTGX? I'm willing to hold it for a few weeks if I have to.
Where do you live? - you must be south of me - it just started to flurry here and they are predicting 6 inches!
bb: Don't know how valid this is, but here are the stats:
Ticker:
CMKI
2000 Sales:
6,184
Major Industry:
Recreation
Sub Industry:
Games & Toys
Country:
United States
Currency:
U.S. Dollars
Fiscal Year Ends:
December
Employees
1
Exchanges:
OTC
Share Type:
Common
Market Capitalization:
8,805,588
Total Shares Outstanding:
352,223,510
Closely Held Shares:
76,660,000
They just bumped the ask to .18 - let's see if it holds.
Back in FTGX.
Whip,
I didn't buy AOR either - saw it too late, but happy for those who got in early today! Good work on LWIN - get out while you still have a profit. I was looking to buy HEA today because of the volume increase. The only thing that stopped me was that the volume has seemed to dry up in the past hour. Take a look and tell me what you think.
Check out AOR - jeez, it just hit a buck on rumors of Berkshire Hathaway buying.
Hate to be the contrarian, but I have had a pretty good day so far - maybe I should quit while I'm still ahead!LOL
Out of GLL at .14 (in yesterday at .10) - still looking strong but I wanted out while I was still ahead!
There goes GLL!
They should give a credit for inconveincing everyone today.
How is Etrade going for you now? I don't want to jinx it, but it is finally running back to normal for me.
I got in today at .10 - I usually never trade AMEX stocks - I know you have been having pretty good luck with them lately.
What do you think of GLL?
Any one with ETRADE problems - try re-booting the computer and then re-launch Market Trader - It just worked for me.
That would be nice - got in last week at .041!
ETRADE is a nightmare! Can't trade - no level II - Market Trader is down!